135 related articles for article (PubMed ID: 29048850)
1. [Stable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinoma].
Wang S; Gao H; Zhang J; Ye X
Se Pu; 2017 Sep; 35(9):934-940. PubMed ID: 29048850
[TBL] [Abstract][Full Text] [Related]
2. Absolute Quantification of
Kim KH; Lee SY; Kim DG; Lee SY; Kim JY; Yoo JS
Anal Chem; 2020 Sep; 92(18):12588-12595. PubMed ID: 32786443
[TBL] [Abstract][Full Text] [Related]
3. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
[TBL] [Abstract][Full Text] [Related]
4. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Int J Mol Sci; 2010 Mar; 11(4):1423-33. PubMed ID: 20480028
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
[TBL] [Abstract][Full Text] [Related]
7. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Analysis Identifies GSN as a Noninvasive Circulating Serum Biomarker for Predicting Early Recurrence of Hepatocellular Carcinoma.
Hu E; Yang T; Cai L; Ouyang J; Wang F; Li Z; Wang Y; Xing X; Liu X
J Proteome Res; 2024 Mar; 23(3):1062-1074. PubMed ID: 38373391
[TBL] [Abstract][Full Text] [Related]
9. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
[TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
12. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
[TBL] [Abstract][Full Text] [Related]
13. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
[TBL] [Abstract][Full Text] [Related]
14. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
[TBL] [Abstract][Full Text] [Related]
15. One-step detection for two serological biomarker species to improve the diagnostic accuracy of hepatocellular carcinoma.
Gao T; Zhi J; Mu C; Gu S; Xiao J; Yang J; Wang Z; Xiang Y
Talanta; 2018 Feb; 178():89-93. PubMed ID: 29136911
[TBL] [Abstract][Full Text] [Related]
16. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
17. The application of proteomics in different aspects of hepatocellular carcinoma research.
Xing X; Liang D; Huang Y; Zeng Y; Han X; Liu X; Liu J
J Proteomics; 2016 Aug; 145():70-80. PubMed ID: 27072111
[TBL] [Abstract][Full Text] [Related]
18. Significant biomarkers for the management of hepatocellular carcinoma.
Kondo Y; Kimura O; Shimosegawa T
Clin J Gastroenterol; 2015 Jun; 8(3):109-15. PubMed ID: 25855582
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
20. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.
Feng JT; Liu YK; Song HY; Dai Z; Qin LX; Almofti MR; Fang CY; Lu HJ; Yang PY; Tang ZY
Proteomics; 2005 Nov; 5(17):4581-8. PubMed ID: 16240287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
